Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gelber

Showing results (61-70 of 395) with videos related to

Pageof 40
Sort By:
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 1, 1995
The Q-TWiST approach to assessing health-related quality of life in epilepsyC E Schwartz, B F Cole, B G Vickrey, et al.
The Journal of Arthroplasty|November 2, 2010
Early range of motion of the scorpio non-restrictive geometry cruciate-retaining total knee systemClifford W Colwell, Jonathan D Gelber, Pamela A Pulido, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Pediatric histiocytosis. Characterization, prognosis, and oral involvementD Filocoma, H L Needleman, R Arceci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysisA Goldhirsch, R D Gelber, R J Simes, et al.
Haematology and Blood Transfusion|January 1, 1990
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trialsS E Sallan, R D Gelber, V Kimball, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Tailoring adjuvant treatments for the individual breast cancer patientR D Gelber, M Bonetti, M Castiglione-Gertsch, et al.
The American Journal of Sports Medicine|April 7, 2017
Outcomes After Arthroscopic Bankart Repair: Patients With First-Time Versus Recurrent DislocationsTyler Marshall, Jose Vega, Marcelo Siqueira, et al.
Pageof 40

Showing results (61-70 of 395) with videos related to

Sort By:
Pageof 40
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|April 1, 1995
The Q-TWiST approach to assessing health-related quality of life in epilepsyC E Schwartz, B F Cole, B G Vickrey, et al.
The Journal of Arthroplasty|November 2, 2010
Early range of motion of the scorpio non-restrictive geometry cruciate-retaining total knee systemClifford W Colwell, Jonathan D Gelber, Pamela A Pulido, et al.
The American Journal of Pediatric Hematology/Oncology|May 1, 1993
Pediatric histiocytosis. Characterization, prognosis, and oral involvementD Filocoma, H L Needleman, R Arceci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1989
Costs and benefits of adjuvant therapy in breast cancer: a quality-adjusted survival analysisA Goldhirsch, R D Gelber, R J Simes, et al.
Haematology and Blood Transfusion|January 1, 1990
More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trialsS E Sallan, R D Gelber, V Kimball, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Lancet (London, England)|August 11, 2001
Polychemotherapy for early breast cancer: an overview of the randomised clinical trials with quality-adjusted survival analysisB F Cole, R D Gelber, S Gelber, et al.
Breast (Edinburgh, Scotland)|December 9, 2003
Tailoring adjuvant treatments for the individual breast cancer patientR D Gelber, M Bonetti, M Castiglione-Gertsch, et al.
The American Journal of Sports Medicine|April 7, 2017
Outcomes After Arthroscopic Bankart Repair: Patients With First-Time Versus Recurrent DislocationsTyler Marshall, Jose Vega, Marcelo Siqueira, et al.
Pageof 40